SCHEMBL13298514

SCHEMBL13298514

c1ccc([SiH2]c2ccc3c(-c4cc5ccccc5c5ccccc45)c4ccccc4c(-c4ccc(-c5ccc6ccccc6c5)cc4)c3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 3/20 0.38
▸ ESR1 P03372 5/20 0.36
▸ ESR2 Q92731 5/20 0.36
▸ SOS1 Q07889 1/20 0.34
▸ HSD17B1 P14061 2/20 0.33
▸ HSD17B2 P37059 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2B6 P20813 1/20 0.33
▸ ALOX5 P09917 3/20 0.33
▸ GSTP1 P09211 1/20 0.32
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ HPRT1 P00492 1/20 0.31
▸ CYP11B1 P15538 1/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298510 1.00 GPR84 (0.38) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298589 0.94 GPR84 (0.38) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298594 0.94 GPR84 (0.38) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298554 0.93 GPR84 (0.37) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298558 0.93 GPR84 (0.37) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298489 0.92 ALOX5 (0.38) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298488 0.92 ALOX5 (0.38) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298520 0.91 GPR84 (0.39) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298527 0.91 GPR84 (0.39) GPR84ESR1ESR2SOS1HSD17B1
SCHEMBL13298484 0.90 ALOX5 (0.40) GPR84ESR1ESR2SOS1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 GPR84 1959/4885ESR1 226/4885ESR2 1338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback